CMS Moves Forward with National Average Drug Acquisition Cost (NADAC) Survey and Publication
CMS first proposed the creation of NADACs last summer. Stakeholders submitted comments regarding that proposal and the current implementation plan, detailed in a “Draft Methodology” document included on the CMS website, responds to that stakeholder input. CMS appears poised to implement the NADAC survey immediately, with survey requests going out to pharmacies as early as today, June 1. Surveys are due within 14 days, which puts CMS in the position to potentially release its first NADAC file at the end of June, for states to use effective July.
Publication of NADACs would represent a significant move toward price transparency in the retail pharmacy marketplace. The public availability of these prices means that private payers and manufacturers also will gain insight into current retail prices, and potentially use those data for their own commercial purposes as well.
CMS is accepting comments on its Draft Methodology until June 21, 2012, at RPS@cms.hhs.gov.
Further detail is available through a Hogan Lovells Health Alert published on June 4, 2012.
On 26 September 2016, a new EU-US collaboration between the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) was announced. This new collaboration is ...06 October 2016
On 1 September 2016, the European Medicines Agency ("EMA") opened for public consultation a Draft revision to its Guideline on the assessment of clinical safety and efficacy in the...08 September 2016